Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
Simple Summary In this survey study, we examined survey responses from 397 women with stage 0 to III unilateral breast cancer and found that partners, physicians, and the media were significant relative to the patient's own influence in their decision to undergo a CPM. The findings of this stud...
Gespeichert in:
Veröffentlicht in: | Cancers 2021-04, Vol.13 (9), p.2050, Article 2050 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 9 |
container_start_page | 2050 |
container_title | Cancers |
container_volume | 13 |
creator | Singareeka Raghavendra, Akshara Alameddine, Hala F. Andersen, Clark R. Selber, Jesse C. Brewster, Abenaa M. Barcenas, Carlos H. Caudle, Abigail S. Arun, Banu K. Tripathy, Debu Ibrahim, Nuhad K. |
description | Simple Summary
In this survey study, we examined survey responses from 397 women with stage 0 to III unilateral breast cancer and found that partners, physicians, and the media were significant relative to the patient's own influence in their decision to undergo a CPM. The findings of this study may inform policy by highlighting the need for educational aids, programs, or tools that help women with unilateral breast cancer make informed, evidence-based decisions regarding CPM efficacy.
(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3) Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients' decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients' decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient's decision to undergo CPM. |
doi_str_mv | 10.3390/cancers13092050 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3390_cancers13092050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2528255024</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-e61ab7b67b9109309965f8b1a7de4e03036cc34f65b1c6486e6a0c03747ab5d33</originalsourceid><addsrcrecordid>eNqNks1vFCEYxonR2Kb27M2QeDExa_kamLmY6Nhqkxo92HgkDPvOLs0MrMC02f9eZrfd1J7kACT8nof35QGh15R84LwhZ9Z4CzFRThpGKvIMHTOi2ELKRjx_tD9CpyndkDI4p0qql-ioyBlThB2j20vfDxPsjHDocV4D_gLWJRc8zgFf-yXEVcBt8DmawWQoM_4Zw2a9HYzNzuLvJmWwOYxbbMbgV_h3GMHjO5fXRe4eNJ8jFBC3u6JfoRe9GRKc3q8n6Pri_Ff7bXH14-tl--lqYQWjeQGSmk51UnUNJU3ps5FVX3fUqCUIIJxwaS0Xvaw6aqWoJUhDLOFKKNNVS85P0Me972bqRlha2HWhN9GNJm51ME7_e-LdWq_Cra4p40TKYvDu3iCGPxOkrEeXLAyD8RCmpFnFSK0Eb-a73j5Bb8IUfWlvpmpWVYSJQp3tKRtDShH6QzGU6DlW_STWonjzuIcD_xBiAeo9cAdd6JN1c5wHrOQuRVOXp5u_AG1dNrmE24bJ5yJ9__9S_hes8sGW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528255024</pqid></control><display><type>article</type><title>Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Singareeka Raghavendra, Akshara ; Alameddine, Hala F. ; Andersen, Clark R. ; Selber, Jesse C. ; Brewster, Abenaa M. ; Barcenas, Carlos H. ; Caudle, Abigail S. ; Arun, Banu K. ; Tripathy, Debu ; Ibrahim, Nuhad K.</creator><creatorcontrib>Singareeka Raghavendra, Akshara ; Alameddine, Hala F. ; Andersen, Clark R. ; Selber, Jesse C. ; Brewster, Abenaa M. ; Barcenas, Carlos H. ; Caudle, Abigail S. ; Arun, Banu K. ; Tripathy, Debu ; Ibrahim, Nuhad K.</creatorcontrib><description>Simple Summary
In this survey study, we examined survey responses from 397 women with stage 0 to III unilateral breast cancer and found that partners, physicians, and the media were significant relative to the patient's own influence in their decision to undergo a CPM. The findings of this study may inform policy by highlighting the need for educational aids, programs, or tools that help women with unilateral breast cancer make informed, evidence-based decisions regarding CPM efficacy.
(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3) Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients' decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients' decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient's decision to undergo CPM.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13092050</identifier><identifier>PMID: 33922702</identifier><language>eng</language><publisher>BASEL: Mdpi</publisher><subject>Breast cancer ; Consent ; Decision making ; Estrogens ; Family medical history ; Influence ; Life Sciences & Biomedicine ; Mastectomy ; Media ; Medical diagnosis ; Mutation ; Oncology ; Pathology ; Patients ; Physicians ; Questionnaires ; Regression analysis ; Science & Technology ; Surgery</subject><ispartof>Cancers, 2021-04, Vol.13 (9), p.2050, Article 2050</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>4</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000649899600001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c421t-e61ab7b67b9109309965f8b1a7de4e03036cc34f65b1c6486e6a0c03747ab5d33</citedby><cites>FETCH-LOGICAL-c421t-e61ab7b67b9109309965f8b1a7de4e03036cc34f65b1c6486e6a0c03747ab5d33</cites><orcidid>0000-0002-5711-2404 ; 0000-0002-6425-4400</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123066/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123066/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33922702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singareeka Raghavendra, Akshara</creatorcontrib><creatorcontrib>Alameddine, Hala F.</creatorcontrib><creatorcontrib>Andersen, Clark R.</creatorcontrib><creatorcontrib>Selber, Jesse C.</creatorcontrib><creatorcontrib>Brewster, Abenaa M.</creatorcontrib><creatorcontrib>Barcenas, Carlos H.</creatorcontrib><creatorcontrib>Caudle, Abigail S.</creatorcontrib><creatorcontrib>Arun, Banu K.</creatorcontrib><creatorcontrib>Tripathy, Debu</creatorcontrib><creatorcontrib>Ibrahim, Nuhad K.</creatorcontrib><title>Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer</title><title>Cancers</title><addtitle>CANCERS</addtitle><addtitle>Cancers (Basel)</addtitle><description>Simple Summary
In this survey study, we examined survey responses from 397 women with stage 0 to III unilateral breast cancer and found that partners, physicians, and the media were significant relative to the patient's own influence in their decision to undergo a CPM. The findings of this study may inform policy by highlighting the need for educational aids, programs, or tools that help women with unilateral breast cancer make informed, evidence-based decisions regarding CPM efficacy.
(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3) Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients' decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients' decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient's decision to undergo CPM.</description><subject>Breast cancer</subject><subject>Consent</subject><subject>Decision making</subject><subject>Estrogens</subject><subject>Family medical history</subject><subject>Influence</subject><subject>Life Sciences & Biomedicine</subject><subject>Mastectomy</subject><subject>Media</subject><subject>Medical diagnosis</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Patients</subject><subject>Physicians</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>Science & Technology</subject><subject>Surgery</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNks1vFCEYxonR2Kb27M2QeDExa_kamLmY6Nhqkxo92HgkDPvOLs0MrMC02f9eZrfd1J7kACT8nof35QGh15R84LwhZ9Z4CzFRThpGKvIMHTOi2ELKRjx_tD9CpyndkDI4p0qql-ioyBlThB2j20vfDxPsjHDocV4D_gLWJRc8zgFf-yXEVcBt8DmawWQoM_4Zw2a9HYzNzuLvJmWwOYxbbMbgV_h3GMHjO5fXRe4eNJ8jFBC3u6JfoRe9GRKc3q8n6Pri_Ff7bXH14-tl--lqYQWjeQGSmk51UnUNJU3ps5FVX3fUqCUIIJxwaS0Xvaw6aqWoJUhDLOFKKNNVS85P0Me972bqRlha2HWhN9GNJm51ME7_e-LdWq_Cra4p40TKYvDu3iCGPxOkrEeXLAyD8RCmpFnFSK0Eb-a73j5Bb8IUfWlvpmpWVYSJQp3tKRtDShH6QzGU6DlW_STWonjzuIcD_xBiAeo9cAdd6JN1c5wHrOQuRVOXp5u_AG1dNrmE24bJ5yJ9__9S_hes8sGW</recordid><startdate>20210423</startdate><enddate>20210423</enddate><creator>Singareeka Raghavendra, Akshara</creator><creator>Alameddine, Hala F.</creator><creator>Andersen, Clark R.</creator><creator>Selber, Jesse C.</creator><creator>Brewster, Abenaa M.</creator><creator>Barcenas, Carlos H.</creator><creator>Caudle, Abigail S.</creator><creator>Arun, Banu K.</creator><creator>Tripathy, Debu</creator><creator>Ibrahim, Nuhad K.</creator><general>Mdpi</general><general>MDPI AG</general><general>MDPI</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5711-2404</orcidid><orcidid>https://orcid.org/0000-0002-6425-4400</orcidid></search><sort><creationdate>20210423</creationdate><title>Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer</title><author>Singareeka Raghavendra, Akshara ; Alameddine, Hala F. ; Andersen, Clark R. ; Selber, Jesse C. ; Brewster, Abenaa M. ; Barcenas, Carlos H. ; Caudle, Abigail S. ; Arun, Banu K. ; Tripathy, Debu ; Ibrahim, Nuhad K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-e61ab7b67b9109309965f8b1a7de4e03036cc34f65b1c6486e6a0c03747ab5d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Breast cancer</topic><topic>Consent</topic><topic>Decision making</topic><topic>Estrogens</topic><topic>Family medical history</topic><topic>Influence</topic><topic>Life Sciences & Biomedicine</topic><topic>Mastectomy</topic><topic>Media</topic><topic>Medical diagnosis</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Patients</topic><topic>Physicians</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>Science & Technology</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singareeka Raghavendra, Akshara</creatorcontrib><creatorcontrib>Alameddine, Hala F.</creatorcontrib><creatorcontrib>Andersen, Clark R.</creatorcontrib><creatorcontrib>Selber, Jesse C.</creatorcontrib><creatorcontrib>Brewster, Abenaa M.</creatorcontrib><creatorcontrib>Barcenas, Carlos H.</creatorcontrib><creatorcontrib>Caudle, Abigail S.</creatorcontrib><creatorcontrib>Arun, Banu K.</creatorcontrib><creatorcontrib>Tripathy, Debu</creatorcontrib><creatorcontrib>Ibrahim, Nuhad K.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singareeka Raghavendra, Akshara</au><au>Alameddine, Hala F.</au><au>Andersen, Clark R.</au><au>Selber, Jesse C.</au><au>Brewster, Abenaa M.</au><au>Barcenas, Carlos H.</au><au>Caudle, Abigail S.</au><au>Arun, Banu K.</au><au>Tripathy, Debu</au><au>Ibrahim, Nuhad K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer</atitle><jtitle>Cancers</jtitle><stitle>CANCERS</stitle><addtitle>Cancers (Basel)</addtitle><date>2021-04-23</date><risdate>2021</risdate><volume>13</volume><issue>9</issue><spage>2050</spage><pages>2050-</pages><artnum>2050</artnum><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Simple Summary
In this survey study, we examined survey responses from 397 women with stage 0 to III unilateral breast cancer and found that partners, physicians, and the media were significant relative to the patient's own influence in their decision to undergo a CPM. The findings of this study may inform policy by highlighting the need for educational aids, programs, or tools that help women with unilateral breast cancer make informed, evidence-based decisions regarding CPM efficacy.
(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3) Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients' decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients' decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient's decision to undergo CPM.</abstract><cop>BASEL</cop><pub>Mdpi</pub><pmid>33922702</pmid><doi>10.3390/cancers13092050</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-5711-2404</orcidid><orcidid>https://orcid.org/0000-0002-6425-4400</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6694 |
ispartof | Cancers, 2021-04, Vol.13 (9), p.2050, Article 2050 |
issn | 2072-6694 2072-6694 |
language | eng |
recordid | cdi_crossref_primary_10_3390_cancers13092050 |
source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Breast cancer Consent Decision making Estrogens Family medical history Influence Life Sciences & Biomedicine Mastectomy Media Medical diagnosis Mutation Oncology Pathology Patients Physicians Questionnaires Regression analysis Science & Technology Surgery |
title | Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A44%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influencers%20of%20the%20Decision%20to%20Undergo%20Contralateral%20Prophylactic%20Mastectomy%20among%20Women%20with%20Unilateral%20Breast%20Cancer&rft.jtitle=Cancers&rft.au=Singareeka%20Raghavendra,%20Akshara&rft.date=2021-04-23&rft.volume=13&rft.issue=9&rft.spage=2050&rft.pages=2050-&rft.artnum=2050&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13092050&rft_dat=%3Cproquest_cross%3E2528255024%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528255024&rft_id=info:pmid/33922702&rfr_iscdi=true |